CJC-1295 + Ipamorelin: third-party lab results, COA-2026-9455
- Compound
- CJC-1295 + Ipamorelin
- Certificate
- COA-2026-9455
- Purity
- 98.65%
- Method
- HPLC (RP-HPLC-UV) with per-component LC-MS
- Identity
- Confirmed
- Testing lab
- Titreon Analytical
- Quality system
- Aligned to ISO/IEC 17025:2017
- Lot
- CI-2603
- CAS
- 863288-34-0 (CJC-1295) blend
- Issued
- 2026-07-02
Mass spec: Per component by LC-MS, ESI positive: Ipamorelin base peak m/z 712.86 (711.9 Da); CJC-1295 (no DAC) deconvolutes to 3367.9 Da.
| Test | Result |
|---|---|
| Peptide Purity (HPLC) | 98.65% (spec >= 95.0%), PASS |
| Net Peptide Content | 10.10 mg (report only), REPORTED |
| Identity (HPLC-RTM) | CJC-1295 + Ipamorelin, Confirmed, PASS |
| Fentanyl Screen | Not Detected (immunoassay, 50 ng/mL), PASS |
| Water (Karl Fischer, USP 921) | 4.80% w/w (spec NMT 8.0% w/w), PASS |
| Counterion (acetate, ion chromatography) | 7.90% w/w (report only), REPORTED |
| Residual Solvents (TFA, USP 467) | Not Detected, PASS |
| Gross Fill Weight (gravimetric) | 11.75 mg (report only), REPORTED |
| Arsenic (As, ICP-MS) | Not Detected (spec NMT 1.5 ppm), PASS |
| Cadmium (Cd, ICP-MS) | Not Detected (spec NMT 0.5 ppm), PASS |
| Chromium (Cr, ICP-MS) | Not Detected (spec NMT 10 ppm), PASS |
| Mercury (Hg, ICP-MS) | Not Detected (spec NMT 1.5 ppm), PASS |
| Lead (Pb, ICP-MS) | Not Detected (spec NMT 1 ppm), PASS |
| Sterility (USP 71) | No Growth, PASS |
| Bioburden (USP 61) | < 1 CFU/mL (spec < 10 CFU/mL), PASS |
| Bacterial Endotoxin (USP 85) | < 0.5 EU/vial (spec NMT 5 EU/mL), PASS |
The Aion CJC-1295 + Ipamorelin blend was tested at 98.65 percent combined purity by HPLC, with both components confirmed by mass spectrometry. The certificate is issued by Titreon Analytical, which operates a quality system aligned to ISO/IEC 17025:2017, under certificate COA-2026-9455.
Because this is a two-peptide blend, the chromatogram resolves both peaks: Ipamorelin at 49.45 area percent and CJC-1295 (no DAC) at 49.20 area percent, with total related substances at 1.35 percent. The panel also covers a fentanyl screen (not detected), water content, residual solvents, five heavy metals by ICP-MS (all not detected), sterility, bioburden, and endotoxin. Every specification passed.
Identity is confirmed per component by LC-MS (ESI positive): the Ipamorelin base peak sits at m/z 712.86 (711.9 Da) and CJC-1295 (no DAC) deconvolutes to 3367.9 Da. Purity is measured by reversed-phase HPLC-UV.
This certificate documents laboratory identity and purity testing only. The compound is sold for research use only, is not approved by the FDA for human use, and nothing here is medical advice.